Published in J Virol on March 01, 1987
A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMBO J (1990) 5.74
An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation. J Virol (1993) 3.72
The duck hepatitis B virus pre-C region encodes a signal sequence which is essential for synthesis and secretion of processed core proteins but not for virus formation. J Virol (1987) 3.39
Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA. J Virol (1991) 3.26
Isolation and characterization of a hepatitis B virus endemic in herons. J Virol (1988) 3.23
Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J Virol (1988) 3.21
Expression and replication of the hepatitis B virus genome under foreign promoter control. Nucleic Acids Res (1987) 2.94
Initiation and termination of duck hepatitis B virus DNA synthesis during virus maturation. J Virol (1987) 2.89
Hepatitis B: the virus and disease. Hepatology (2009) 2.48
Expression of the precore region of an avian hepatitis B virus is not required for viral replication. J Virol (1987) 2.42
Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol (1994) 2.41
Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. Am J Pathol (2000) 2.23
Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J Virol (1988) 2.11
A bulged region of the hepatitis B virus RNA encapsidation signal contains the replication origin for discontinuous first-strand DNA synthesis. J Virol (1996) 2.07
Identification and characterization of the woodchuck hepatitis virus origin of DNA replication. J Virol (1990) 2.00
Posttranscriptional regulation of hepatitis B virus replication by the precore protein. J Virol (1997) 1.96
Expression of the hepatitis B virus core gene in vitro and in vivo. J Virol (1987) 1.96
In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus. Antimicrob Agents Chemother (1989) 1.90
Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer. J Virol (1989) 1.88
Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism. Proc Natl Acad Sci U S A (2001) 1.88
Nucleotide priming and reverse transcriptase activity of hepatitis B virus polymerase expressed in insect cells. J Virol (1995) 1.83
Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation. J Virol (2007) 1.80
Mutations in the epsilon sequences of human hepatitis B virus affect both RNA encapsidation and reverse transcription. J Virol (1995) 1.77
Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus. J Virol (1992) 1.76
Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol (1991) 1.61
Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J (1990) 1.54
Transcomplementation of nucleotide priming and reverse transcription between independently expressed TP and RT domains of the hepatitis B virus reverse transcriptase. J Virol (1997) 1.50
Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest (1996) 1.48
Molecular biology of hepatitis B virus infection. Virology (2015) 1.47
The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol (2005) 1.43
Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice. J Virol (2001) 1.43
Tight clustering of human hepatitis B virus integration sites in hepatomas near a triple-stranded region. J Virol (1987) 1.42
Characterization and genetic analysis of alternatively spliced transcripts of hepatitis B virus in infected human liver tissues and transfected HepG2 cells. J Virol (1991) 1.32
Identification of a doubly spliced viral transcript joining the separated domains for putative protease and reverse transcriptase of hepatitis B virus. J Virol (1989) 1.31
Internal entry of ribosomes and ribosomal scanning involved in hepatitis B virus P gene expression. J Virol (1989) 1.31
Pregenomic RNA encapsidation analysis of eleven missense and nonsense polymerase mutants of human hepatitis B virus. J Virol (1991) 1.30
Identification of protein-binding sites in the hepatitis B virus enhancer and core promoter domains. Mol Cell Biol (1988) 1.26
Differentiation-specific transcriptional regulation of the hepatitis B virus large surface antigen gene in human hepatoma cell lines. J Virol (1990) 1.26
Hepatitis delta virus (HDV) and woodchuck hepatitis virus (WHV) nucleic acids in tissues of HDV-infected chronic WHV carrier woodchucks. J Virol (1989) 1.26
Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease. J Virol (1996) 1.21
Chromosomal translocation and inverted duplication associated with integrated hepatitis B virus in hepatocellular carcinomas. J Virol (1987) 1.21
Mapping of the hepatitis B virus reverse transcriptase TP and RT domains by transcomplementation for nucleotide priming and by protein-protein interaction. J Virol (1999) 1.20
Identification of a promoter region for 3.6-kilobase mRNA of hepatitis B virus and specific cellular binding protein. J Virol (1989) 1.19
Promoters for synthesis of the pre-C and pregenomic mRNAs of human hepatitis B virus are genetically distinct and differentially regulated. J Virol (1996) 1.19
Identification and cloning of a novel heterogeneous nuclear ribonucleoprotein C-like protein that functions as a transcriptional activator of the hepatitis B virus enhancer II. J Virol (1992) 1.17
cis rescue of a mutated reverse transcriptase gene of human hepatitis B virus by creation of an internal ATG. J Virol (1990) 1.17
In vivo regulation of hepatitis B virus replication by peroxisome proliferators. J Virol (1999) 1.15
The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitro. Antimicrob Agents Chemother (2007) 1.13
Detection and mapping of spliced RNA from a human hepatoma cell line transfected with the hepatitis B virus genome. Proc Natl Acad Sci U S A (1989) 1.13
Overlapping initiator and TATA box functions in the basal core promoter of hepatitis B virus. J Virol (1995) 1.12
Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression. J Virol (1998) 1.12
Potent inhibition of hepatitis B virus production in vitro by modified pyrimidine nucleosides. Antimicrob Agents Chemother (1990) 1.12
Characterization of functional Sp1 transcription factor binding sites in the hepatitis B virus nucleocapsid promoter. J Virol (1993) 1.11
Base pairing between cis-acting sequences contributes to template switching during plus-strand DNA synthesis in human hepatitis B virus. J Virol (2007) 1.11
Replication of the wild type and a natural hepatitis B virus nucleocapsid promoter variant is differentially regulated by nuclear hormone receptors in cell culture. J Virol (2001) 1.09
The arginine clusters of the carboxy-terminal domain of the core protein of hepatitis B virus make pleiotropic contributions to genome replication. J Virol (2010) 1.09
In vitro infection of human hepatoma (HepG2) cells with hepatitis B virus. J Virol (1990) 1.09
Avian hepatitis B viruses: molecular and cellular biology, phylogenesis, and host tropism. World J Gastroenterol (2007) 1.08
cis-Acting sequences that contribute to the synthesis of relaxed-circular DNA of human hepatitis B virus. J Virol (2004) 1.08
Serine phosphoacceptor sites within the core protein of hepatitis B virus contribute to genome replication pleiotropically. PLoS One (2011) 1.05
Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients. J Virol (1997) 1.03
A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency. J Virol (2001) 1.03
Evidence that the 5'-end cap structure is essential for encapsidation of hepatitis B virus pregenomic RNA. J Virol (2000) 1.03
Mechanisms of inhibition of nuclear hormone receptor-dependent hepatitis B virus replication by hepatocyte nuclear factor 3beta. J Virol (2002) 1.01
Developmental regulation of hepatitis B virus biosynthesis by hepatocyte nuclear factor 4alpha. PLoS One (2009) 1.00
Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor. J Virol (1992) 0.99
Identification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II. J Virol (2000) 0.98
Defective replication units of hepatitis B virus. J Virol (1990) 0.96
Interaction between hepatitis B virus core protein and reverse transcriptase. J Virol (2000) 0.95
Mutations that increase in situ priming also decrease circularization for duck hepatitis B virus. J Virol (2001) 0.95
cis-Acting sequences 5E, M, and 3E interact to contribute to primer translocation and circularization during reverse transcription of avian hepadnavirus DNA. J Virol (2002) 0.93
Antiviral treatment of chronic hepatitis B virus (HBV) infections. Viruses (2010) 0.93
Functional characterization of the interferon regulatory element in the enhancer 1 region of the hepatitis B virus genome. Nucleic Acids Res (2002) 0.93
Core protein: A pleiotropic keystone in the HBV lifecycle. Antiviral Res (2015) 0.93
The sequence of the RNA primer and the DNA template influence the initiation of plus-strand DNA synthesis in hepatitis B virus. J Mol Biol (2007) 0.92
Hepatocyte nuclear factor 3beta inhibits hepatitis B virus replication in vivo. J Virol (2002) 0.92
Age-related differences in amplification of covalently closed circular DNA at early times after duck hepatitis B virus infection of ducks. J Virol (2005) 0.91
Complementarity between epsilon and phi sequences in pregenomic RNA influences hepatitis B virus replication efficiency. Virology (2006) 0.91
Establishment and primary application of a mouse model with hepatitis B virus replication. World J Gastroenterol (2007) 0.89
Properties of monoclonal antibodies directed against hepatitis B virus polymerase protein. J Virol (1999) 0.89
MicroRNA-26b inhibits hepatitis B virus transcription and replication by targeting the host factor CHORDC1 protein. J Biol Chem (2014) 0.89
Molecular biology of the hepatitis B virus for clinicians. J Clin Exp Hepatol (2012) 0.87
Avian and Mammalian hepadnaviruses have distinct transcription factor requirements for viral replication. J Virol (2002) 0.87
Multiple nuclear receptors may regulate hepatitis B virus biosynthesis during development. Int J Biochem Cell Biol (2009) 0.86
Regulatory sequences of duck hepatitis B virus C gene transcription. J Virol (1991) 0.86
Replicative intermediate of hepatitis B virus in transfected murine fibroblasts. J Virol (1987) 0.86
Peroxisome proliferator-activated receptor gamma Coactivator 1alpha and small heterodimer partner differentially regulate nuclear receptor-dependent hepatitis B virus biosynthesis. J Virol (2009) 0.85
Integrated hepatitis B virus DNA preserves the binding sequence of transcription factor Yin and Yang 1 at the virus-cell junction. J Virol (2000) 0.83
Nucleic acid chaperone activity associated with the arginine-rich domain of human hepatitis B virus core protein. J Virol (2013) 0.83
Limited effects of fasting on hepatitis B virus (HBV) biosynthesis in HBV transgenic mice. J Virol (2008) 0.83
Clinical relevance of hepatitis B virus variants. World J Hepatol (2015) 0.83
Identification of two separable modules in the duck hepatitis B virus core protein. J Virol (1995) 0.82
Changing the site of initiation of plus-strand DNA synthesis inhibits the subsequent template switch during replication of a hepadnavirus. J Virol (1998) 0.82
Duck hepatitis B virus polymerase acts as a suppressor of core protein translation. J Virol (1996) 0.81
Independent activation of hepatitis B virus biosynthesis by retinoids, peroxisome proliferators, and bile acids. J Virol (2012) 0.81
Role of peroxisome proliferator-activated receptor gamma coactivator 1alpha in AKT/PKB-mediated inhibition of hepatitis B virus biosynthesis. J Virol (2011) 0.80
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids. Cell (1977) 61.24
Mapping of RNA by a modification of the Berk-Sharp procedure: the 5' termini of 15 S beta-globin mRNA precursor and mature 10 s beta-globin mRNA have identical map coordinates. Nucleic Acids Res (1979) 31.23
Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem (1980) 26.55
Spliced early mRNAs of simian virus 40. Proc Natl Acad Sci U S A (1978) 18.67
Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate. Cell (1982) 16.71
Rates of formation and thermal stabilities of RNA:DNA and DNA:DNA duplexes at high concentrations of formamide. Nucleic Acids Res (1977) 15.92
Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature (1979) 15.42
A reliable method for the recovery of DNA fragments from agarose and acrylamide gels. Anal Biochem (1981) 15.38
Hepatitis B virus genes and their expression in E. coli. Nature (1979) 10.83
Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol (1984) 6.90
Hepatitis B virus contains protein attached to the 5' terminus of its complete DNA strand. Cell (1980) 5.21
Signals regulating hepatitis B surface antigen transcription. Nature (1983) 5.02
Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen. Proc Natl Acad Sci U S A (1986) 4.73
Transcripts and the putative RNA pregenome of duck hepatitis B virus: implications for reverse transcription. Cell (1985) 4.41
Biochemical and genetic evidence for the hepatitis B virus replication strategy. Science (1986) 4.12
Mapping the major transcripts of ground squirrel hepatitis virus: the presumptive template for reverse transcriptase is terminally redundant. Cell (1985) 3.78
Analysis of processing and polyadenylation signals of the hepatitis B virus surface antigen gene by using simian virus 40-hepatitis B virus chimeric plasmids. Mol Cell Biol (1983) 3.63
Evidence that a capped oligoribonucleotide is the primer for duck hepatitis B virus plus-strand DNA synthesis. J Virol (1986) 3.46
Hepatitis B virus transcription in the infected liver. EMBO J (1984) 3.44
Mapping of the cohesive overlap of duck hepatitis B virus DNA and of the site of initiation of reverse transcription. J Virol (1984) 2.72
Transcription of woodchuck hepatitis virus in the chronically infected liver. EMBO J (1985) 2.49
Infectious hepatitis B virus from cloned DNA of known nucleotide sequence. Proc Natl Acad Sci U S A (1985) 2.20
Core and E antigen synthesis in rodent cells transformed with hepatitis B virus DNA is associated with greater than genome length viral messenger RNAs. J Mol Biol (1983) 2.20
Evidence for the direct involvement of DNA replication origin in synthesis of late SV40 RNA. Nature (1982) 2.20
Putative reverse transcriptase intermediates of human hepatitis B virus in primary liver carcinomas. Science (1986) 2.00
Hepatitis B viral DNA-RNA hybrid molecules in particles from infected liver are converted to viral DNA molecules during an endogenous DNA polymerase reaction. Virology (1984) 1.72
Asymmetric replication of hepatitis B virus DNA in human liver: demonstration of cytoplasmic minus-strand DNA by blot analyses and in situ hybridization. Virology (1984) 1.48
The HBV HBX gene expressed in E. coli is recognised by sera from hepatitis patients. EMBO J (1985) 1.45
Novel RNA family structure of hepatitis B virus expressed in human cells, using a helper-free adenovirus vector. J Virol (1986) 1.31
A recombinant Chinese hamster ovary cell line containing a 300-fold amplified tetramer of the hepatitis B genome together with a double selection marker expresses high levels of viral protein. J Mol Biol (1986) 1.23
The mechanism of replication of hepatitis B virus: evidence of asymmetric replication of the two DNA strands. J Med Virol (1984) 1.18
Hepatitis B virus DNA in Dane particles: evidence for the presence of replicative intermediates. J Infect Dis (1985) 0.97
Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5. Gene (1982) 13.62
Hepatitis B virus genes and their expression in E. coli. Nature (1979) 10.83
A new sensitive method for qualitative and quantitative assay of neomycin phosphotransferase in crude cell extracts. Gene (1984) 7.36
Nucleotide sequence of bacteriophage fd DNA. Nucleic Acids Res (1978) 7.25
Nucleotide sequence of an RNA polymerase binding site from the DNA of bacteriophage fd. Proc Natl Acad Sci U S A (1975) 7.14
RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell (1991) 6.97
Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature (2000) 6.67
Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science (1992) 6.49
Structural analysis of Tn5. Cold Spring Harb Symp Quant Biol (1981) 6.16
High-level hepatitis B virus replication in transgenic mice. J Virol (1995) 5.81
A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMBO J (1990) 5.74
RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure determines position and efficiency. Cell (1993) 5.62
Nucleotide sequence of the origin of replication of the Escherichia coli K-12 chromosome. Proc Natl Acad Sci U S A (1979) 5.31
The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation. J Virol (1990) 5.19
Signals regulating hepatitis B surface antigen transcription. Nature (1983) 5.02
Interaction of RNA polymerase with promoters from bacteriophage fd. Eur J Biochem (1977) 4.94
Penicillinase from Bacillus licheniformis: nucleotide sequence of the gene and implications for the biosynthesis of a secretory protein in a Gram-positive bacterium. Nucleic Acids Res (1981) 4.94
Comparative sequence analysis of duck and human hepatitis B virus genomes. J Med Virol (1985) 4.68
Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J Virol (1990) 4.57
Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science (1999) 4.56
Transcripts and the putative RNA pregenome of duck hepatitis B virus: implications for reverse transcription. Cell (1985) 4.41
A mammalian RNA editing enzyme. Nature (1996) 3.90
Characterization of foot-and-mouth disease virus gene products with antisera against bacterially synthesized fusion proteins. J Virol (1986) 3.89
Nucleotide sequence and genome organization of foot-and-mouth disease virus. Nucleic Acids Res (1984) 3.81
Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. EMBO J (1992) 3.78
Conversion of bacteriophage fd into an efficient single-stranded DNA vector system. Mol Gen Genet (1980) 3.57
The amino-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription. EMBO J (1988) 3.52
Structure of the orgin of DNA replication of bacteriophage fd. Proc Natl Acad Sci U S A (1978) 3.52
Hepatitis B virus transcription in the infected liver. EMBO J (1984) 3.44
The ras-related YPT1 gene product in yeast: a GTP-binding protein that might be involved in microtubule organization. Cell (1986) 3.40
The duck hepatitis B virus pre-C region encodes a signal sequence which is essential for synthesis and secretion of processed core proteins but not for virus formation. J Virol (1987) 3.39
A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol (1995) 3.35
Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. EMBO J (1982) 3.32
Synthesis and encapsidation of duck hepatitis B virus reverse transcriptase do not require formation of core-polymerase fusion proteins. Cell (1989) 3.31
Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J Virol (1998) 3.27
Isolation and characterization of a hepatitis B virus endemic in herons. J Virol (1988) 3.23
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med (1995) 3.20
Transposition of a DNA sequence determining kanamycin resistance into the single-stranded genome of bacteriophage fd. Mol Gen Genet (1978) 3.19
Function of DNA polymerase 3 in DNA replication. Nat New Biol (1971) 3.10
Production of hepatitis B virus in vitro by transient expression of cloned HBV DNA in a hepatoma cell line. EMBO J (1987) 3.09
Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family. Science (1989) 3.03
Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem (1996) 3.00
Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J Cell Biol (1997) 2.98
Expression and replication of the hepatitis B virus genome under foreign promoter control. Nucleic Acids Res (1987) 2.94
Codon-improved Cre recombinase (iCre) expression in the mouse. Genesis (2002) 2.92
Adenine nucleotide translocation of mitochondria. 1. Specificity and control. Eur J Biochem (1968) 2.91
Initiation of deoxyribonucleic acid synthesis. VII. A unique location of the gap in the M13 replicative duplex synthesized in vitro. J Biol Chem (1974) 2.85
Measles virus spread and pathogenesis in genetically modified mice. J Virol (1998) 2.84
Cloned HBV DNA causes hepatitis in chimpanzees. Nature (1982) 2.80
Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science (1995) 2.78
Affinity chromatography of DNA-binding enzymes on single-stranded DNA-agarose columns. Eur J Biochem (1972) 2.76
Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J Immunol (1990) 2.73
Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology (2001) 2.71
The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem (1998) 2.71
Structure of the DNA of bacteriophage fd. II. Isolation and characterization of a DNA fraction with double strand-like properties. J Mol Biol (1969) 2.71
Ilizarov treatment of tibial nonunions with bone loss. Clin Orthop Relat Res (1989) 2.71
Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J (1987) 2.67
RED2, a brain-specific member of the RNA-specific adenosine deaminase family. J Biol Chem (1996) 2.64
Deoxyribonucleic acid replication in vitro. J Mol Biol (1972) 2.64
Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem (1997) 2.63
RNA editing of brain glutamate receptor channels: mechanism and physiology. Brain Res Brain Res Rev (1998) 2.62
Nucleotide sequence and corresponding amino acid sequence of the gene for the major antigen of foot and mouth disease virus. Nucleic Acids Res (1981) 2.61
Structure of the FMDV translation initiation site and of the structural proteins. Nucleic Acids Res (1983) 2.58
Biased hypermutation of viral RNA genomes could be due to unwinding/modification of double-stranded RNA. Cell (1989) 2.54
Biochemical and immunological characterization of the duck hepatitis B virus envelope proteins. J Virol (1987) 2.50
Cerebellar GABAA receptor selective for a behavioural alcohol antagonist. Nature (1990) 2.50
A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J (1998) 2.48
Single RNA polymerase binding site isolated. Nat New Biol (1972) 2.47
The duck hepatitis B virus core protein contains a highly phosphorylated C terminus that is essential for replication but not for RNA packaging. J Virol (1989) 2.47
Mapping and characterization of promoters in bacteriophages fd, f1 and m13. J Mol Biol (1975) 2.46
Expression of the precore region of an avian hepatitis B virus is not required for viral replication. J Virol (1987) 2.42
Hepatitis B virus replication. Trends Microbiol (1993) 2.41
Landmark-based elastic registration using approximating thin-plate splines. IEEE Trans Med Imaging (2001) 2.40
Two novel GABAA receptor subunits exist in distinct neuronal subpopulations. Neuron (1989) 2.38
Isolation and characterization of thermosensitive Escherichia coli mutants defective in deoxyribonucleic acid replication. J Bacteriol (1973) 2.38
Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J (2000) 2.38
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis (2010) 2.38
Autoregulation of fos: the dyad symmetry element as the major target of repression. EMBO J (1989) 2.37
Retracted Infectious measles virus from cloned cDNA. EMBO J (1990) 2.36
GABA- and glutamate-activated channels in green fluorescent protein-tagged gonadotropin-releasing hormone neurons in transgenic mice. J Neurosci (1999) 2.28
Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. J Virol (1989) 2.27
Translational inactivation of RNA function: discrimination against a subset of genomic transcripts during HBV nucleocapsid assembly. Cell (1990) 2.26
IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. J Immunol (1992) 2.24
The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J Biol Chem (1999) 2.21